<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(1)</volume><submitter>Chevalier E</submitter><pubmed_abstract>Abnormal cytoplasmic localization and accumulation of pathological transactive response DNA binding protein of 43 kDa (TDP-43) underlies several devastating diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP). A key element is the correlation between disease progression and spatio-temporal propagation of TDP-43-mediated pathology in the central nervous system. Several lines of evidence support the concept of templated aggregation and cell to cell spreading of pathological TDP-43. To further investigate this mechanism in vivo, we explored the efficacy of capturing and masking the seeding-competent region of extracellular TDP-43 species. For this, we generated a novel monoclonal antibody (mAb), ACI-6677, that targets the</pubmed_abstract><journal>Acta neuropathologica communications</journal><pagination>156</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11448013</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Targeting the TDP-43 low complexity domain blocks spreading of pathology in a mouse model of ALS/FTD.</pubmed_title><pmcid>PMC11448013</pmcid><pubmed_authors>Chevalier E</pubmed_authors><pubmed_authors>Afroz T</pubmed_authors><pubmed_authors>Pfeifer A</pubmed_authors><pubmed_authors>Piorkowska K</pubmed_authors><pubmed_authors>Audrain M</pubmed_authors><pubmed_authors>Ratnam M</pubmed_authors><pubmed_authors>Ollier R</pubmed_authors><pubmed_authors>Seredenina T</pubmed_authors><pubmed_authors>Kosco-Vilbois M</pubmed_authors><pubmed_authors>Fuchs A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Targeting the TDP-43 low complexity domain blocks spreading of pathology in a mouse model of ALS/FTD.</name><description>Abnormal cytoplasmic localization and accumulation of pathological transactive response DNA binding protein of 43 kDa (TDP-43) underlies several devastating diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP). A key element is the correlation between disease progression and spatio-temporal propagation of TDP-43-mediated pathology in the central nervous system. Several lines of evidence support the concept of templated aggregation and cell to cell spreading of pathological TDP-43. To further investigate this mechanism in vivo, we explored the efficacy of capturing and masking the seeding-competent region of extracellular TDP-43 species. For this, we generated a novel monoclonal antibody (mAb), ACI-6677, that targets the</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2025-04-04T02:00:01.11Z</modification><creation>2025-04-04T02:00:01.11Z</creation></dates><accession>S-EPMC11448013</accession><cross_references><pubmed>39363348</pubmed><doi>10.1186/s40478-024-01867-z</doi></cross_references></HashMap>